Pharmacology
Summary
The first-order elimination rate constant, symbolized by k or ke, describes the fraction of a drug removed from the body over a defined unit of time. Unlike other elimination types, the proportion of the drug metabolized over time remains constant for most drugs at typical dosages. This rate constant is essential for computing the drug's plasma concentration at any given time by considering the initial concentration, the rate constant itself, and the elapsed time. Another essential concept is half-life (t1/2), representing the duration required to eliminate 50% of the drug from the body. Calculated as t1/2=0.693/k (where 0.693 is the natural log of 2), the half-life offers insights into drug dosing frequencies to sustain therapeutic levels and the time needed to eradicate the drug entirely from the system.
Reaching a steady state in drug administration implies a balance where the amount of drug introduced equals the amount eliminated. Typically, around five half-lives are needed for a drug to attain this state (considering a one-compartment model and first-order kinetics). Likewise, approximately five half-lives are are needed for the body to clear ~97% of most drugs after the final dose. Maintaining this steady state within the therapeutic range is vital for effective treatment. A drug's half-life can also inform clinical decisions, especially when considering the implications of delayed or missed doses. For instance, medications with extended half-lives, like warfarin (~40 hours), might allow more flexibility, while those with shorter half-lives, such as rivaroxaban (~12 hours), may require stricter adherence.
Lesson Outline
Don't stop here!
Get access to 133 more Pharmacology lessons & 13 more medical school learning courses with one subscription!
FAQs
The elimination rate constant, often represented as 'k' or 'ke', is the fraction of a drug that is eliminated from the body over a set unit of time. This is important as it can be used to calculate the plasma concentration of a drug at any given time and formulate dosing schedules. Specifically, the rate constant governs how quickly a drug will be cleared from the body. Most drugs at most dosages follow first-order kinetics, meaning the proportion of the drug metabolized over time remains constant.
The half-life of a drug, or t1/2, is calculated as 0.693 divided by the elimination rate constant (k). The half-life is the time it takes for the quantity of a drug in the body to be reduced by 50%. This value provides critical information in determining how often a drug should be administered in order to maintain a steady state, as well as how long it will take to fully eliminate the drug from the body.
A steady state is achieved when the amount of drug administered equals the amount being eliminated from the body. It typically takes about five half-lives for a drug to reach this state. The steady state is important as it should ideally fall within the therapeutic range, providing the desired treatment effects without causing harmful side effects.
Understanding a drug's half-life is essential for determining its dosing schedule. For example, a drug with a long half-life, such as warfarin (~40 hours), might not require as frequent dosing, and will thus be more forgiving if a dose is missed or delayed. Conversely, a drug with a short half-life, like rivaroxaban (~12 hours), will need to be administered more frequently, and a missed or delayed dose could have more significant clinical implications.
Complete elimination from the body, or reaching close to zero concentration, generally takes about five half-lives of the drug after the final dose is administered. This applies to most drugs under the one-compartment model and first-order kinetics, resulting in roughly 97% of the drug being eliminated during this period.
MCAT® is a registered trademark of the Association of American Medical Colleges. The United States Medical Licensing Examination (USMLE®) is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). NAPLEX® is a registered trademark of the National Association of Boards of Pharmacy. PANCE© is a registered trademark of the National Commission on Certification of Physician Assistants. NCLEX® is a registered trademark and service mark of the National Council of State Boards of Nursing, Inc. None of the trademark holders are endorsed by nor affiliated with Sketchy or this website.
